Table 3.
Group 1 | Group 2 | Group 3 | ||||
---|---|---|---|---|---|---|
Sr | P | Sr | P | Sr | P | |
Age | −0.71 (59) | < 0.0001 | − 0.72 (30) | < 0.0001 | − 0.62 (141) | < 0.0001 |
Years since diagnosis | − 0.20 (59) | 0.14 | 0.03 (30) | 0.89 | n.a. | n.a. |
RAI activity | −0.11 (59) | 0.38 | n.a. | n.a. | n.a. | n.a |
BMI | 0.02(59) | 0.84 | 0.05 (30) | 0.81 | 0.01 (132) | 0.93 |
L-T4 dosage/week | 0.13 (59) | 0.32 | −0.11 (30) | 0.55 | n.a | n.a |
TSH | −0.04 (59) | 0.78 | 0.16 (30) | 0.40 | 0.14 (121) | 0.12 |
f-T4 | 0.06 (59) | 0.65 | 0.32 (30) | 0.09 | −0.13 (105) | 0.19 |
Thyroglobulin | −0.05 (59) | 0.78 | 0.04 (30) | 0.81 | n.a | n.a. |
FSH | −0.55 (56) | < 0.0001 | −0.77 (30) | < 0.0001 | − 0.46 (102) | < 0.0001 |
Estradiol | −0.13 (54) | 0.35 | 0.20 (28) | 0.30 | −0.16 (98) | 0.12 |
Progesterone | 0.28 (52) | 0.05 | 0.28 (26) | 0.16 | −0.18 (85) | 0.09 |
PRL | 0.09 (57) | 0.52 | 0.09 (26) | 0.68 | −0.11 (97) | 0.26 |
n.a. Not applicable